--- title: "NATIONSTAR released its performance for the first three quarters, with a net profit attributable to the parent company of 31.12 million yuan, a year-on-year decrease of 53.35%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/262770530.md" description: "According to the Zhitong Finance APP, NATIONSTAR disclosed its third-quarter report for 2025. The company achieved revenue of 2.5 billion yuan in the first three quarters, a year-on-year decrease of 7.01%; the net profit attributable to the parent company was 31.12 million yuan, a year-on-year decrease of 53.35%; the net profit excluding non-recurring gains and losses was 12.99 million yuan, a year-on-year decrease of 63.36%; the basic earnings per share were 0.0503 yuan" datetime: "2025-10-26T10:32:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262770530.md) - [en](https://longbridge.com/en/news/262770530.md) - [zh-HK](https://longbridge.com/zh-HK/news/262770530.md) --- > 支持的语言: [English](https://longbridge.com/en/news/262770530.md) | [繁體中文](https://longbridge.com/zh-HK/news/262770530.md) # NATIONSTAR released its performance for the first three quarters, with a net profit attributable to the parent company of 31.12 million yuan, a year-on-year decrease of 53.35% According to the Zhitong Finance APP, NATIONSTAR (002449.SZ) disclosed its third-quarter report for 2025. The company achieved a revenue of 2.5 billion yuan in the first three quarters, a year-on-year decrease of 7.01%; the net profit attributable to shareholders was 31.12 million yuan, a year-on-year decrease of 53.35%; the net profit excluding non-recurring items was 12.99 million yuan, a year-on-year decrease of 63.36%; the basic earnings per share were 0.0503 yuan ### 相关股票 - [NATIONSTAR (002449.CN)](https://longbridge.com/zh-CN/quote/002449.CN.md) ## 相关资讯与研究 - [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/zh-CN/news/278597263.md) - [BYD, Geely, Isuzu and Nissan Adopt NVIDIA DRIVE Hyperion for Level 4 Vehicles | NVDA Stock News](https://longbridge.com/zh-CN/news/279318750.md) - [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/zh-CN/news/279052280.md) - [Paralympics-Broken kit, no problem: the Paralympics rapid‑repair lifeline](https://longbridge.com/zh-CN/news/279096386.md) - [A Look At Star Plus Legend Holdings’ Valuation As Guidance Swings From Profit To Loss](https://longbridge.com/zh-CN/news/279105880.md)